Physician profile
Juan F Yepes
NPI 1265532451
$131,466.25
in general payments reported to CMS, 2019-2025
11 companies · $55K in 2025
The $55K reported for 2025 was more than what 99% of Pediatric Dentistry providers received nationally (typical 2025 total: $42.86).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,984 · 2020: $16K · 2021: $3,516 · 2022: $13K · 2023: $17K · 2024: $23K · 2025: $55K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $36K · Consulting Fee: $20K · Travel and Lodging: $15K · Long Term Medical Supply Or Device Loan: $15K · Honoraria: $7,250 · Food and Beverage: $1,517 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $35,521.50 |
| Consulting Fee | $19,890.00 |
| Travel and Lodging | $15,144.37 |
| Long Term Medical Supply Or Device Loan | $14,995.00 |
| Honoraria | $7,250.00 |
| Food and Beverage | $1,516.95 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $830.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $38,045.12 | 2023-2025 | Crysvita |
| Alexion Pharmaceuticals, INC. | $34,121.13 | 2019-2025 | Strensiq |
| Air Techniques, INC. | $25,391.50 | 2020-2025 | 3d Provecta, Flowstar Nitrous, Scan X Ortho |
| Straumann USA LLC | $14,995.00 | 2025 | |
| Septodont INC. | $14,825.17 | 2020-2025 | Bioroot Rcs |
| Tokuyama Dental America INC. | $2,250.00 | 2024 | |
| Nusmile, Ltd. | $1,737.49 | 2020 | |
| Kerr Corporation | $38.26 | 2021 | |
| Colgate Oral Pharmaceuticals, INC. | $27.17 | 2023 | Prevident |
| 3m Company | $20.88 | 2021 | |
| Smith+Nephew, INC. | $14.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Yepes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.